In:
Access Microbiology, Microbiology Society, Vol. 3, No. 8 ( 2021-08-26)
Abstract:
We compared neutralization assays using either the wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus or surrogate neutralization markers, using characterized sera. We found the results of the neutralization assays 75 % concordant overall and 80 % concordant for samples with high antibody levels. This demonstrates that commercial surrogate SARS-CoV-2 assays offer the potential to assess anti-SARS-CoV-2 antibodies’ neutralizing capacity outside CL-3 laboratory containment.
Type of Medium:
Online Resource
ISSN:
2516-8290
DOI:
10.1099/acmi.0.000257
Language:
English
Publisher:
Microbiology Society
Publication Date:
2021
detail.hit.zdb_id:
2973602-X
Permalink